Norden Group LLC Acquires 147 Shares of CME Group Inc. (NASDAQ:CME)

Norden Group LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.4% in the first quarter, Holdings Channel.com reports. The firm owned 6,330 shares of the financial services provider’s stock after purchasing an additional 147 shares during the period. Norden Group LLC’s holdings in CME Group were worth $1,679,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Bank Pictet & Cie Europe AG increased its position in shares of CME Group by 29.0% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider’s stock valued at $20,190,000 after acquiring an additional 19,533 shares in the last quarter. American Century Companies Inc. increased its position in shares of CME Group by 7.3% during the fourth quarter. American Century Companies Inc. now owns 52,432 shares of the financial services provider’s stock valued at $12,176,000 after acquiring an additional 3,587 shares in the last quarter. New Age Alpha Advisors LLC increased its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 43 shares in the last quarter. Orion Portfolio Solutions LLC increased its position in shares of CME Group by 0.7% during the fourth quarter. Orion Portfolio Solutions LLC now owns 10,465 shares of the financial services provider’s stock valued at $2,430,000 after acquiring an additional 73 shares in the last quarter. Finally, Allstate Corp bought a new stake in shares of CME Group during the fourth quarter valued at approximately $2,482,000. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Up 0.9%

Shares of CME Group stock opened at $279.55 on Monday. The company’s fifty day simple moving average is $276.44 and its 200-day simple moving average is $262.72. The stock has a market capitalization of $100.74 billion, a PE ratio of 27.06, a P/E/G ratio of 4.96 and a beta of 0.44. CME Group Inc. has a 1-year low of $193.25 and a 1-year high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.56 EPS. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.79%. The ex-dividend date of this dividend was Monday, June 9th. CME Group’s dividend payout ratio is presently 48.40%.

Insider Buying and Selling at CME Group

In other news, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the transaction, the director owned 2,915 shares in the company, valued at $790,781.20. This trade represents a 25.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director owned 3,108 shares in the company, valued at $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,400 shares of company stock worth $3,152,410. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Bank of America raised their price target on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research report on Wednesday, April 2nd. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Piper Sandler raised their price target on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Morgan Stanley raised their price target on shares of CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a research report on Thursday, April 24th. Finally, Royal Bank Of Canada restated a “sector perform” rating and issued a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.